default author photo

Peiyan Kong

Government of the People's Republic of China - Medical Center of Hematology

Chongqing

China

SCHOLARLY PAPERS

5

DOWNLOADS

544

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

Genomic Profiling of Plasma Circulating Tumor DNA Reveals Genetics and Residual Disease in Extranodal NK/T-Cell Lymphoma

Number of pages: 25 Posted: 22 Aug 2019
Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 135 (544,251)

Abstract:

Loading...

ENKTL, Circulating tumor DNA, mutation allele frequency, minimal residual disease, prognosis

2.

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

Number of pages: 84 Posted: 02 Dec 2019
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Army Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Provincial People's Hospital, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Government of the People's Republic of China - Tangdu Hospital - Department of Hematology, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Government of the People's Republic of China - Sichuan Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Chengdu Military Region of the PLA, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Xinjiang Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Department of Hematology, City of Hope - Beckman Research Institute, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 129 (561,789)

Abstract:

Loading...

acute myeloid leukemia; high risk; allogeneic hematopoietic stem cell transplantation; decitabine; granulocyte colony-stimulating factor; relapse

3.

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

Number of pages: 84 Posted: 26 Nov 2019
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - College of Preventive Medicine, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Provincial People's Hospital, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Government of the People's Republic of China - Tangdu Hospital, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Government of the People's Republic of China - Sichuan Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Chengdu Military Region of the PLA, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Xinjiang Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Department of Hematology, City of Hope - Beckman Research Institute, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 119 (600,462)

Abstract:

Loading...

acute myeloid leukemia; high risk; allogeneic hematopoietic stem cell transplantation; decitabine; granulocyte colony-stimulating factor; relapse

4.

Tandem Autologous Hematopoietic Stem Cell Transplantation for Treatment of Adult T-Cell Lymphoblastic Lymphoma: A Multiple Center Prospective Study in Southwestern China

Number of pages: 31 Posted: 16 Jan 2019
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Second Yunnan Provincial People's Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 119 (600,462)

Abstract:

Loading...

T-cell lymphoblastic lymphoma, autologous hematopoietic stem cell transplantation, progression-free survival, progression/relapse rate, overall survival

5.

THBS1 Is a Novel Serum Prognostic Factors of Acute Myeloid Leukemia

Number of pages: 29 Posted: 11 Jun 2019
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Army Medical University - Hematology Medical Center, Army Medical University - Hematology Medical Center, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 42 (1,157,785)

Abstract:

Loading...

Acute myeloid leukemia, Protein microarray, serum protein markers, THBS1, promoter methylation